Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 501–600 of 1,084
Stimulation of proangiogenesis by calcium silicate bioactive ceramic
Li, H., & Chang, J. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.10.019 · Cited by 241
“Neovascularization is a critical problem that the development of bone tissue engineering faces due to the difficulties of angiogenesis in engineered bone constructs larger than a few millimeters in volume [31–36].”
BackgroundLee, S. L. C., Rouhi, P., Jensen, L. D., Zhang, D., Ji, H., Hauptmann, G., Ingham, P., & Cao, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909228106 · Cited by 240
Chamorro-Jorganes, A., Araldi, E., Penalva, L. O. F., Sandhu, D., Fernández-Hernando, C., & Suárez, Y. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.236521 · Cited by 240
Sulforaphane as a promising molecule for fighting cancer
Fimognari, C., & Hrelia, P. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.10.004 · Cited by 240
“Angiogenesis is the physiological process of formation of new blood vessels, essential for normal tissue growth, but it is also the mechanism that allows the tumor to nourish itself, to expand, and to form metastases [10].”
BackgroundImproving Penetration in Tumors With Nanoassemblies of Phospholipids and Doxorubicin
Tang, N., Du, G., Wang, N., Liu, C., Hang, H., & Liang, W. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm027 · Cited by 239
Microenvironmental and cellular consequences of altered blood flow in tumours
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · The British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240
“the ‘‘angiogenic switch’’, is triggered or selected for by various signals, including low pO2, low pH and low glucose [6].”
BackgroundRecent Development of pH-Responsive Polymers for Cancer Nanomedicine
Tang, H., Zhao, W., Yu, J., Li, Y., & Zhao, C. (2018) · Molecules · doi:10.3390/molecules24010004 · Cited by 239
“Targeting cancer-specific biomarkers offers great opportunities for precise tumor detection and efficacious drug delivery, and more importantly, causes minimal side effects on normal cells [5].”
BackgroundApplications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?
Hoseini-Ghahfarokhi, M., Mirkiani, S., Mozaffari, N., Abdolahi Sadatlu, M. A., Ghasemi, A., Abbaspour, S., Akbarian, M., Farjadain, F., & Karimi, M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s265876 · Cited by 239
Guiding Lights: Tissue Bioprinting Using Photoactivated Materials
Lee, M., Rizzo, R., Surman, F., & Zenobi-Wong, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00077 · Cited by 239
Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor
Qi, F., Li, A., Inagaki, Y., Kokudo, N., Tamura, S., Nakata, M., & Tang, W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.007 · Cited by 238
Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology
Witte, M. H., Bernas, M. J., Martin, C. P., & Witte, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1163 · Cited by 238
“…Pullinger and Florey, 1937; and Bellman and Odén, 1958–59, respectively). tential application to “ischemic” treatment of cancer (Witzenbichler et al., 1998), tumor lymphangiogenesis was until just recently thought by many to be nonexistent (Carmeliet and Jain, 2000; Folkman, 1995; Jain, 1989).”
BackgroundChaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64993 · Cited by 238
“Tumor vasculature is structurally and functionally abnormal, leading to spatial and temporal heterogeneity in perfusion, even in tumors with active angiogenesis (4, 5).”
Gao, W., Xiang, B., Meng, T.-T., Liu, F., & Qi, X.-R. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.014 · Cited by 238
Engineering bioinks for 3D bioprinting
Decante, G., Costa, J. B., Silva-Correia, J., Collins, M. N., Reis, R. L., & Oliveira, J. M. (2021) · Biofabrication · doi:10.1088/1758-5090/abec2c · Cited by 237
“In vivo , most living cells lie within 100–200 µ m from at least a single capillary from vascular network, corresponding to the diffusion limit of oxygen [253, 254].”
Natural killer cell-triggered vascular transformation: maternal care before birth?
Zhang, J., Chen, Z., Smith, G. N., & Croy, B. A. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.38 · Cited by 237
Takeda, K., Cowan, A., & Fong, G.-H. (2007) · Circulation · doi:10.1161/circulationaha.107.701516 · Cited by 236
Epigallocatechin 3-gallate: From green tea to cancer therapeutics
Alam, M., Ali, S., Ashraf, G. M., Bilgrami, A. L., Yadav, D. K., & Hassan, M. I. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.132135 · Cited by 236
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Mihaly, J., Prager, G., & Binder, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-11-0669 · Cited by 236
Ferreira, L. S., Gerecht, S., Shieh, H. F., Watson, N., Rupnick, M. A., Dallabrida, S. M., Vunjak-Novakovic, G., & Langer, R. (2007) · Circulation Research · doi:10.1161/circresaha.107.150201 · Cited by 236
“different steps: (1) the differentiation of hESCs through EBs”
BackgroundStain-free histopathology by programmable supercontinuum pulses
Tu, H., Liu, Y., Turchinovich, D., Marjanovic, M., Lyngsø, J. K., Lægsgaard, J., Chaney, E. J., Zhao, Y., You, S., Wilson, W. L., et al. (2016) · Nature Photonics · doi:10.1038/nphoton.2016.94 · Cited by 233
“In another specimen, there is image-based evidence that the vascularized stroma in the cancerous tissue is degrading adipose tissue, supporting the previous literature that these vesicles can be linked to angiogenesis 23,24 , a known hallmark of cancer 25 .”
Metastatic Colorectal Cancer: From Improved Survival to Potential Cure
Gallagher, D. J., & Kemeny, N. (2010) · Oncology · doi:10.1159/000315730 · Cited by 235
“but median OS (21.9 vs. 19.9, p = 0.0769) and RR (47p vs. 49p, p = 0.31) were similar in both arms. Furthermore, the PFS benefit was limited to the XELOX arm (9.3 vs. 7.4 months, p = 0.003 but for FOLFOX: 9.4 vs. 8.6 months, p = 0.19). More patients discontinued treatment because of adverse events, including thromboem…”
BackgroundInfluentialAnti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy
Dulak, J., & Jozkowicz, A. (2005) · Current Cancer Drug Targets · doi:10.2174/156800905774932824 · Cited by 235
“Some data also indicate de novo formation of blood vessels in growing tumors [1, 5].”
BackgroundPredicting benefit from anti-angiogenic agents in malignancy
Jubb, A. M., Oates, A. J., Holden, S., & Koeppen, H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1946 · Cited by 228
“jpg" NDATA ITEM> ]> Angiogenesis, the sprouting or intussusception of parent blood vessels to form new vessels, is essential for the growth of large tumour”
BackgroundNovel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro
Leite, S. B., Roosens, T., El Taghdouini, A., Mannaerts, I., Smout, A. J., Najimi, M., Sokal, E., Noor, F., Chesne, C., & van Grunsven, L. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.026 · Cited by 234
VEGF-A in Cardiomyocytes and Heart Diseases
Braile, M., Marcella, S., Cristinziano, L., Galdiero, M. R., Modestino, L., Ferrara, A. L., Varricchi, G., Marone, G., & Loffredo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155294 · Cited by 234
Fibronectin in Cancer: Friend or Foe
Lin, T.-C., Yang, C.-H., Cheng, L.-H., Chang, W.-T., Lin, Y.-R., & Cheng, H.-C. (2019) · Cells · doi:10.3390/cells9010027 · Cited by 234
Mabuchi, S., Altomare, D. A., Cheung, M., Zhang, L., Poulikakos, P. I., Hensley, H. H., Schilder, R. J., Ozols, R. F., & Testa, J. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2770 · Cited by 234
Computer simulation of glioma growth and morphology
Frieboes, H. B., Lowengrub, J. S., Wise, S., Zheng, X., Macklin, P., Bearer, E. L., & Cristini, V. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.008 · Cited by 234
“Chaotic angiogenesis leads to perfusion in the tumor that then might be responsible for regression of parts vascular network and necrosis of tumor cells (Carmeliet & Jain, 2000, Patan et 2001b), further enhancing variable tumor cell proliferation.”
BackgroundEvading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Abdollahi, A., & Folkman, J. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2009.12.001 · Cited by 233
“Adapted, with permission from (Carmeliet and Jain, 2000) Nature Publishing Group©.”
Calvani, M., Rapisarda, A., Uranchimeg, B., Shoemaker, R. H., & Melillo, G. (2006) · Blood · doi:10.1182/blood-2005-09-3541 · Cited by 230
Autophagy in endothelial cells and tumor angiogenesis
Schaaf, M. B., Houbaert, D., Meçe, O., & Agostinis, P. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0287-8 · Cited by 232
Designing nanomedicine for immuno-oncology
Jiang, W., von Roemeling, C. A., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 229
Melanoma–stroma interactions: structural and functional aspects
Ruiter, D., Bogenrieder, T., Elder, D., & Herlyn, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00620-9 · Cited by 231
Cancer prevention – the potential for diet to modulate molecular signalling
Manson, M. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00002-3 · Cited by 231
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
Mitola, S., Belleri, M., Urbinati, C., Coltrini, D., Sparatore, B., Pedrazzi, M., Melloni, E., & Presta, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.12 · Cited by 229
“Angiogenesis, the growth of new blood vessels from pre-existing ones, plays an important role in various pathological settings, including inflammation, wound repair, and tumor growth (12).”
Antiangiogenic therapy for cancer: current and emerging concepts.
Coiffier, B., & Reyes, F. (2005) · PubMed · Cited by 231
Van der Auwera, I., Van Laere, S. J., Van den Eynden, G. G., Benoy, I., van Dam, P., Colpaert, C. G., Fox, S. B., Turley, H., Harris, A. L., Van Marck, E. A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0063 · Cited by 227
“The occurrence of metastasis in breast cancer is correlated with the extent of new blood vessel growth (2), which is now recognized both as a promising prognostic indicator (13) and a target for therapy (14, 15).”
BackgroundMetastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment
Kopfstein, L., & Christofori, G. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5296-8 · Cited by 229
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Sosa Iglesias, V., Giuranno, L., Dubois, L. J., Theys, J., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00267 · Cited by 229
“One of the major problems with anti-VEGF therapy in the clinic is the increased levels of hypoxia leading to more aggressive treatment-resistant tumor cell populations, but it also leads to hemoptysis, hypertension, and arterial thrombus embolism due to effects on the normal vasculature in the heart, endocrine and ner…”
BackgroundArvizo, R. R., Rana, S., Miranda, O. R., Bhattacharya, R., Rotello, V. M., & Mukherjee, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.01.011 · Cited by 229
“This neovascular development from preexisting vessels is essential for the growth and progression of tumors [2, 3] in which vascular endothelial growth factor (VEGF) has been recognized as the prominent cytokine in the angiogenic cascade [4].”
BackgroundSequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311227 · Cited by 229
Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids
Luo, H., Jiang, B.-H., King, S. M., & Chen, Y. C. (2008) · Nutrition and Cancer · doi:10.1080/01635580802100851 · Cited by 224
“Antiangiogenesis has recently become the focus of the study for cancer therapy and prevention (4).”
BackgroundThe role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 228
“A. (2010b). Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev.”
BackgroundInfluentialKim, J.-H., Kim, Y.-S., Park, K., Kang, E., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Chi, D. Y., Park, R.-W., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.038 · Cited by 228
Jüttner, S., Wiβmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P. M., Kemmner, W., & Höcker, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.3467 · Cited by 228
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
Han, X., Liao, R., Li, X., Zhang, C., Huo, S., Qin, L., Xiong, Y., He, T., Xiao, G., & Zhang, T. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02313-9 · Cited by 227
“449 Numerous studies suggest that MSCs contribute to tumor angiogenesis by differentiating into pericytes or endothelial-like cells.”
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedKumar, A., Mandal, S., Barui, S., Vasireddi, R., Gbureck, U., Gelinsky, M., & Basu, B. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.01.001 · Cited by 225
Lu, L., Payvandi, F., Wu, L., Zhang, L.-H., Hariri, R. J., Man, H.-W., Chen, R. S., Muller, G. W., Hughes, C. C. W., Stirling, D. I., et al. (2009) · Microvascular Research · doi:10.1016/j.mvr.2008.08.003 · Cited by 225
Chen, P.-S., Shih, Y.-W., Huang, H.-C., & Cheng, H.-W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020164 · Cited by 225
“Angiogenesis, a critical step in tumor growth and metastasis, is regulated by a variety of angiogenic factors, such as VEGF [51].”
BackgroundInfluentialEffects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes
Lolmède, K., Durand de Saint Front, V, Galitzky, J., Lafontan, M., & Bouloumié, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802407 · Cited by 224
The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis
Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., Huszar, M., White, M. R., Dinarello, C. A., & Apte, R. N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901511 · Cited by 224
Diez, H., Fischer, A., Winkler, A., Hu, C.-J., Hatzopoulos, A. K., Breier, G., & Gessler, M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.009 · Cited by 224
“solid tumors) secrete high levels of VEGF and other growth factors, which lead to activation and attraction of endothelial cells and formation of new blood vessels [32].”
BackgroundProgressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., & Ruoslahti, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00273-3 · Cited by 224
Tumor hypoxia: From basic knowledge to therapeutic implications
Liao, C., Liu, X., Zhang, C., & Zhang, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.011 · Cited by 223
Dong, X., Liu, H.-J., Feng, H.-Y., Yang, S.-C., Liu, X.-L., Lai, X., Lu, Q., Lovell, J. F., Chen, H.-Z., & Fang, C. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04236 · Cited by 223
Laha, D., Grant, R., Mishra, P., & Nilubol, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656908 · Cited by 213
“In contrast with normal healthy vasculature, neovascular growth in cancers is imperfect, exhibiting a non-continuous endothelium and a sporadically present or absent basement membrane, which increases vessel permeability (16).”
BackgroundSchistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
Costain, A. H., MacDonald, A. S., & Smits, H. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03042 · Cited by 222
“This sequential process is guided by pro-angiogenic factors (such as VEGF, angiopoietin and inflammatory cell-derived chemokines) which instruct endothelial cell activation, proliferation and reorganization (50).”
BackgroundKopp, H.-G., Ramos, C. A., & Rafii, S. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219664.26528.da · Cited by 220
“Within the VEGF family of cytokines, VEGF-A is the most potent mediator of the angiogenic switch [81,82].”
BackgroundNeutrophils: important contributors to tumor progression and metastasis
Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9594-9 · Cited by 220
“Angiogenesis is essential for continued tumor growth [144].”
BackgroundMetabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
Ohshima, K., & Morii, E. (2021) · Metabolites · doi:10.3390/metabo11010028 · Cited by 220
“To obtain enough oxygen to survive, cancer cells must reside within 100–200 μm of functional vasculatures, which represents the diffusion limit of oxygen in tissues [56,57].”
BackgroundDrogat, B., Auguste, P., Nguyen, D. T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R. J., Chevet, E., Bikfalvi, A., & Moenner, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3235 · Cited by 220
“Angiogenesis represents a critical step in tumor development and is functionally linked to ischemia parameters, including hypoxia and glucose deprivation (1, 5, 38 ).”
BackgroundAnderson, C. R., Hu, X., Zhang, H., Tlaxca, J., Declèves, A.-E., Houghtaling, R., Sharma, K., Lawrence, M., Ferrara, K. W., & Rychak, J. J. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e3182034fed · Cited by 219
“Angiogenesis, the growth of new blood vessels from existing vessels, is a fundamental component of tumor growth and metastasis.(1) Angiogenic endothelial cells exhibit drastic changes in the expression of cell surface molecules, including integrins that modulate cell adhesion, migration, and survival through interacti…”
BackgroundAngiogenesis, lymphangiogenesis, and melanoma metastasis
Streit, M., & Detmar, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206457 · Cited by 219
“…represent an alternative therapeutic target for long-term treatment of melanoma, since tumor progression appears to be angiogenesis dependent and because vascular endothelial cells do not have the genetic instability that allows cancer cells to develop drug resistance (Carmeliet and Jain, 2000).”
BackgroundGastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer
Saif, M. W., Elfiky, A., & Salem, R. R. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9337-9 · Cited by 219
van der Schaft, D. W. J., Seftor, R. E. B., Seftor, E. A., Hess, A. R., Gruman, L. M., Kirschmann, D. A., Yokoyama, Y., Griffioen, A. W., & Hendrix, M. J. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh267 · Cited by 219
Angiogenesis in chronic inflammatory liver disease
Medina, J., Arroyo, A. G., Sánchez-Madrid, F., & Moreno-Otero, R. (2004) · Hepatology · doi:10.1002/hep.20193 · Cited by 219
Matsui, J., Wakabayashi, T., Asada, M., Yoshimatsu, K., & Okada, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311643200 · Cited by 219
Tumor microenvironment in ovarian cancer: function and therapeutic strategy
Yang, Y., Yang, Y., Yang, J., Zhao, X., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00758 · Cited by 218
Markowska, A. I., Jefferies, K. C., & Panjwani, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226423 · Cited by 218
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J.-P. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 218
“The formation of new blood vessels is critical for tumor progression as the mass grows bigger [23], while existing blood and lymphatic vessels may act as routes for local invasion and distant metastasis [24, 25].”
BackgroundKang, S.-G., Zhou, G., Yang, P., Liu, Y., Sun, B., Huynh, T., Meng, H., Zhao, L., Xing, G., Chen, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204600109 · Cited by 218
“In the process of tumor proliferation beyond a certain size, a cancer tissue suffers from oxygen and nutrient deficiencies, for which new but chaotic blood vessels are formed around the tumor tissue by angiogenesis and vasculogenesis (3).”
BackgroundCombretastatins: from natural products to drug discovery
Cirla, A., & Mann, J. (2003) · Natural Product Reports · doi:10.1039/b306797c · Cited by 218
Saunders, W. B., Bayless, K. J., & Davis, G. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.02360 · Cited by 215
“Other studies present a different view, stating that proteinases such as plasmin and soluble MMPs stimulate angiogenic responses by promoting basement membrane degradation and ECM proteolysis necessary for EC invasion and sprouting (Carmeliet and Jain, 2000; Foda and Zucker, 2001; Pepper, 2001; Sternlicht and Werb, 20…”
BackgroundInfluentialOptical Imaging of Cancer Metastasis to Bone Marrow
Wetterwald, A., van der Pluijm, G., Que, I., Sijmons, B., Buijs, J., Karperien, M., Löwik, C. W. G. M., Gautschi, E., Thalmann, G. N., & Cecchini, M. G. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64934-6 · Cited by 217
“Thus, the model lacks the sensitivity that would be necessary to dissect the initial processes, such as the “angiogenic switch,”(14) essential for tumor progression.(15) Furthermore, the radiological detection of osteolytic and/or osteosclerotic metastases is an indirect measure of the tumor burden.”
BackgroundTang, R., Xue, J., Xu, B., Shen, D., Sudlow, G. P., & Achilefu, S. (2015) · ACS Nano · doi:10.1021/nn5071183 · Cited by 217
“support and previous studies have shown its high binding affinity to ABIR, which is widely expressed in diverse cancer cells and tumor-associated blood vessels.(27,28) For NIR fluorescence imaging of cells and deep tissues, we used the 820 nmemitting Ag2SQDs as representative QDs to prepare the QD peptide conjugates.”
MethodApigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expression
Fang, J., Zhou, Q., Liu, L.-Z., Xia, C., Hu, X., Shi, X., & Jiang, B.-H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl205 · Cited by 216
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
Yan, X. (2003) · Blood · doi:10.1182/blood-2002-04-1004 · Cited by 214
“In 2 steps, approximately 300 hybridomas were screened for clones producing antibodies that (1) bound to the cell surfaces of stimulated HUVECs but not primary HUVECs and (2) recognized tumor neovasculature in hepatocarcinoma, but not blood vessels from normal liver tissues.”
BackgroundImaging of tumor angiogenesis in rat brains in vivo by photoacoustic tomography
Ku, G., Wang, X., Xie, X., Stoica, G., & Wang, L. V. (2005) · Applied Optics · doi:10.1364/ao.44.000770 · Cited by 219
Examination of the foreign body response to biomaterials by nonlinear intravital microscopy
Dondossola, E., Holzapfel, B. M., Alexander, S., Filippini, S., Hutmacher, D. W., & Friedl, P. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0007 · Cited by 215
Molecular Mechanisms of Tumor Angiogenesis
Ziyad, S., & Iruela-Arispe, M. L. (2011) · Genes & Cancer · doi:10.1177/1947601911432334 · Cited by 215
Zhang, Y., Zheng, D., Zhou, T., Song, H., Hulsurkar, M., Su, N., Liu, Y., Wang, Z., Shao, L., Ittmann, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06177-2 · Cited by 215
High-throughput kinase profiling as a platform for drug discovery
Goldstein, D. M., Gray, N. S., & Zarrinkar, P. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2541 · Cited by 215
Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration
Cao, G., O'Brien, C. D., Zhou, Z., Sanders, S. M., Greenbaum, J. N., Makrigiannakis, A., & DeLisser, H. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00524.2001 · Cited by 215
“In terms of EC, angiogenesis can be viewed as a process in which these cells sever their initial cell-cell contacts, proliferate, and migrate into the perivascular matrix where they reestablish their cell-cell associations to form new patent vascular channels (11).”
BackgroundR Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Cao, Y., Cao, R., & Hedlund, E.-M. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0337-z · Cited by 215
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
Knopp, M. V., Giesel, F. L., Marcos, H. B., von Tengg‐Kobligk, H., & Choyke, P. L. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00006 · Cited by 215
“Fundamental to tumor growth is the ability of some tumors to switch on the angiogenic process (the so-called angiogenic switch) that leads to exponential induction of new vessel formation and increased vascular leakiness (12).”
BackgroundThe dynamic role of platelets in cancer progression and their therapeutic implications
Li, S., Lu, Z., Wu, S., Chu, T., Li, B., Qi, F., Zhao, Y., & Nie, G. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00639-6 · Cited by 214
Janani, S., Rajagopal, H., Muthu, S., Aayisha, S., & Raja, M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129657 · Cited by 214
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
Unger, R. E., Ghanaati, S., Orth, C., Sartoris, A., Barbeck, M., Halstenberg, S., Motta, A., Migliaresi, C., & Kirkpatrick, C. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.057 · Cited by 214
“After implantation of a biomaterial with cells, interstitial fluid diffusion is the only source of nourishment for the cells on the biomaterial and this is limited to a depth of about 200 mm into the biomaterial [1,2].”
Biology of Angiogenesis and Invasion in Glioma
Tate, M. C., & Aghi, M. K. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.001 · Cited by 213
Tumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212
“As all cells need to be located within a close proximity of blood vessels providing oxygen and nutrients, solid tumors cannot grow beyond a few millimetres in diameter without being able to recruit their own blood supply (6, 7).”
BackgroundSupply of Nutrients to Cells in Engineered Tissues
Rouwkema, J., Koopman, B. F. J. M., Blitterswijk, C. A. V., Dhert, W. J. A., & Malda, J. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-163 · Cited by 202
“This number, which correlates to a maximum distance of a cell to the nearest capillary of 150 microns, correlates well with the maximum oxygen diffusion range (Carmeliet and Jain 2000).”
BackgroundJoyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Imaging of integrin αvβ3 expression
Beer, A. J., & Schwaiger, M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9158-3 · Cited by 211
“One trigger is an insufficient nutrient supply resulting in hypoxic cells [16].”
BackgroundYue, P. Y. K., Mak, N. K., Cheng, Y. K., Leung, K. W., Ng, T. B., Fan, D. T. P., Yeung, H. W., & Wong, R. N. S. (2007) · Chinese Medicine · doi:10.1186/1749-8546-2-6 · Cited by 211
“Inadequate angiogenesis can also cause serious pathological outcomes such as stroke, Alzheimer disease, chronic wound, ulceration, ischemic coronary artery, critical limb ischemia, hypertension and hair loss [62,63].”
Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay
Cross, L. M., Cook, M. A., Lin, S., Chen, J.-N., & Rubinstein, A. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000068685.72914.7e · Cited by 211
Winkler, F., Kienast, Y., Fuhrmann, M., Von Baumgarten, L., Burgold, S., Mitteregger, G., Kretzschmar, H., & Herms, J. (2009) · Glia · doi:10.1002/glia.20850 · Cited by 210
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells
MU, H., OHASHI, R., YAN, S., CHAI, H., YANG, H., LIN, P., YAO, Q., & CHEN, C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.015 · Cited by 210
“Dysregulated angiogenesis is involved in pathological conditions such as ischemic heart diseases, cancer, diabetes, or chronic inflammation including atherosclerosis [14].”
BackgroundHypoxia‐inducible factor‐1 and oncogenic signalling
Bárdos, J. I., & Ashcroft, M. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 206
“sion by stimulating angiogenesis in response to inadequate vascularisation and changes in intratumoural hypoxia.((4)) A key”
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.